Human bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with age

Wendy W. Pang1, Elizabeth Price2, Debashis Sahoo3, Isabel Beerman4, William J. Maloney5, Derrick J. Rossi4, Stanley L. Schrier2, Irving L. Weissman3
1Institute for Stem Cell Biology and Regenerative Medicine, Ludwig Center for Stem Cell Research, and Department of Pathology, Stanford University, Stanford, CA 94305, USA.
2Department of Internal Medicine, Division of Hematology, and
3Institute for Stem Cell Biology and Regenerative Medicine, Ludwig Center for Stem Cell Research, and Department of Pathology,
4Immune Disease Institute, Harvard Medical School, Boston, MA 02115
5Department of Orthopaedic Surgery, Stanford University, Stanford, CA 94305; and

Tóm tắt

In the human hematopoietic system, aging is associated with decreased bone marrow cellularity, decreased adaptive immune system function, and increased incidence of anemia and other hematological disorders and malignancies. Recent studies in mice suggest that changes within the hematopoietic stem cell (HSC) population during aging contribute significantly to the manifestation of these age-associated hematopoietic pathologies. Though the mouse HSC population has been shown to change both quantitatively and functionally with age, changes in the human HSC and progenitor cell populations during aging have been incompletely characterized. To elucidate the properties of an aged human hematopoietic system that may predispose to age-associated hematopoietic dysfunction, we evaluated immunophenotypic HSC and other hematopoietic progenitor populations from healthy, hematologically normal young and elderly human bone marrow samples. We found that aged immunophenotypic human HSC increase in frequency, are less quiescent, and exhibit myeloid-biased differentiation potential compared with young HSC. Gene expression profiling revealed that aged immunophenotypic human HSC transcriptionally up-regulate genes associated with cell cycle, myeloid lineage specification, and myeloid malignancies. These age-associated alterations in the frequency, developmental potential, and gene expression profile of human HSC are similar to those changes observed in mouse HSC, suggesting that hematopoietic aging is an evolutionarily conserved process.

Từ khóa


Tài liệu tham khảo

D Bryder, DJ Rossi, IL Weissman, Hematopoietic stem cells: The paradigmatic tissue-specific stem cell. Am J Pathol 169, 338–346 (2006).

SM Chambers, et al., Aging hematopoietic stem cells decline in function and exhibit epigenetic dysregulation. PLoS Biol 5, e201 (2007).

M Kim, HB Moon, GJ Spangrude, Major age-related changes of mouse hematopoietic stem/progenitor cells. Ann N Y Acad Sci 996, 195–208 (2003).

SJ Morrison, AM Wandycz, K Akashi, A Globerson, IL Weissman, The aging of hematopoietic stem cells. Nat Med 2, 1011–1016 (1996).

DJ Pearce, F Anjos-Afonso, CM Ridler, A Eddaoudi, D Bonnet, Age-dependent increase in side population distribution within hematopoiesis: Implications for our understanding of the mechanism of aging. Stem Cells 25, 828–835 (2007).

DJ Rossi, et al., Cell intrinsic alterations underlie hematopoietic stem cell aging. Proc Natl Acad Sci USA 102, 9194–9199 (2005).

K Sudo, H Ema, Y Morita, H Nakauchi, Age-associated characteristics of murine hematopoietic stem cells. J Exp Med 192, 1273–1280 (2000).

RH Cho, HB Sieburg, CE Muller-Sieburg, A new mechanism for the aging of hematopoietic stem cells: Aging changes the clonal composition of the stem cell compartment but not individual stem cells. Blood 111, 5553–5561 (2008).

CE Muller-Sieburg, RH Cho, L Karlsson, JF Huang, HB Sieburg, Myeloid-biased hematopoietic stem cells have extensive self-renewal capacity but generate diminished lymphoid progeny with impaired IL-7 responsiveness. Blood 103, 4111–4118 (2004).

B Dykstra, et al., Long-term propagation of distinct hematopoietic differentiation programs in vivo. Cell Stem Cell 1, 218–229 (2007).

I Beerman, et al., Functionally distinct hematopoietic stem cells modulate hematopoietic lineage potential during aging by a mechanism of clonal expansion. Proc Natl Acad Sci USA 107, 5465–5470 (2010).

GA Challen, NC Boles, SM Chambers, MA Goodell, Distinct hematopoietic stem cell subtypes are differentially regulated by TGF-beta1. Cell Stem Cell 6, 265–278 (2010).

Y Morita, H Ema, H Nakauchi, Heterogeneity and hierarchy within the most primitive hematopoietic stem cell compartment. J Exp Med 207, 1173–1182 (2010).

T Ogawa, M Kitagawa, K Hirokawa, Age-related changes of human bone marrow: A histometric estimation of proliferative cells, apoptotic cells, T cells, B cells and macrophages. Mech Ageing Dev 117, 57–68 (2000).

PJ Linton, K Dorshkind, Age-related changes in lymphocyte development and function. Nat Immunol 5, 133–139 (2004).

JP Miller, D Allman, The decline in B lymphopoiesis in aged mice reflects loss of very early B-lineage precursors. J Immunol 171, 2326–2330 (2003).

JM Guralnik, RS Eisenstaedt, L Ferrucci, HG Klein, RC Woodman, Prevalence of anemia in persons 65 years and older in the United States: Evidence for a high rate of unexplained anemia. Blood 104, 2263–2268 (2004).

MA Lichtman, JM Rowe, The relationship of patient age to the pathobiology of the clonal myeloid diseases. Semin Oncol 31, 185–197 (2004).

M Bhatia, JC Wang, U Kapp, D Bonnet, JE Dick, Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice. Proc Natl Acad Sci USA 94, 5320–5325 (1997).

CM Baum, IL Weissman, AS Tsukamoto, AM Buckle, B Peault, Isolation of a candidate human hematopoietic stem-cell population. Proc Natl Acad Sci USA 89, 2804–2808 (1992).

B Péault, IL Weissman, AM Buckle, A Tsukamoto, C Baum, Thy-1-expressing CD34+ human cells express multiple hematopoietic potentialities in vitro and in SCID-hu mice. Nouv Rev Fr Hematol 35, 91–93 (1993).

JM McCune, et al., The SCID-hu mouse: Murine model for the analysis of human hematolymphoid differentiation and function. Science 241, 1632–1639 (1988).

RS Negrin, et al., Transplantation of highly purified CD34+Thy-1+ hematopoietic stem cells in patients with metastatic breast cancer. Biol Blood Marrow Transplant 6, 262–271 (2000).

L Murray, et al., Analysis of human hematopoietic stem cell populations. Blood Cells 20, 364–369, discussion 369–370. (1994).

PM Lansdorp, W Dragowska, H Mayani, Ontogeny-related changes in proliferative potential of human hematopoietic cells. J Exp Med 178, 787–791 (1993).

RE Gale, AK Fielding, CN Harrison, DC Linch, Acquired skewing of X-chromosome inactivation patterns in myeloid cells of the elderly suggests stochastic clonal loss with age. Br J Haematol 98, 512–519 (1997).

SB Marley, et al., Evidence for a continuous decline in haemopoietic cell function from birth: Application to evaluating bone marrow failure in children. Br J Haematol 106, 162–166 (1999).

DA Lipschitz, CO Mitchell, C Thompson, The anemia of senescence. Am J Hematol 11, 47–54 (1981).

C Kollman, et al., Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: The effect of donor age. Blood 98, 2043–2051 (2001).

A Waterstrat, et al. Telomeres and Telomerase in Ageing, Disease, and Cancer, ed KL Rudolph (Springer, Berlin), pp. 111–140 (2008).

E Taraldsrud, et al., Age and stress related phenotypical changes in bone marrow CD34+ cells. Scand J Clin Lab Invest 69, 79–84 (2009).

I Beerman, WJ Maloney, IL Weissmann, DJ Rossi, Stem cells and the aging hematopoietic system. Curr Opin Immunol 22, 500–506 (2010).

R Majeti, CY Park, IL Weissman, Identification of a hierarchy of multipotent hematopoietic progenitors in human cord blood. Cell Stem Cell 1, 635–645 (2007).

MG Manz, T Miyamoto, K Akashi, IL Weissman, Prospective isolation of human clonogenic common myeloid progenitors. Proc Natl Acad Sci USA 99, 11872–11877 (2002).

VG Tusher, R Tibshirani, G Chu, Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98, 5116–5121 (2001).

SM Chambers, et al., Hematopoietic fingerprints: An expression database of stem cells and their progeny. Cell Stem Cell 1, 578–591 (2007).

K Nalapareddy, H Jiang, LM Guachalla Gutierrez, KL Rudolph, Determining the influence of telomere dysfunction and DNA damage on stem and progenitor cell aging: What markers can we use? Exp Gerontol 43, 998–1004 (2008).

IL Weissman, Normal and neoplastic stem cells. Novartis Found Symp 265, 35–50, discussion 50–54, 92–97. (2005).

MR Lieber, ZE Karanjawala, Ageing, repetitive genomes and DNA damage. Nat Rev Mol Cell Biol 5, 69–75 (2004).

A Nijnik, et al., DNA repair is limiting for haematopoietic stem cells during ageing. Nature 447, 686–690 (2007).

DJ Rossi, et al., Hematopoietic stem cell quiescence attenuates DNA damage response and permits DNA damage accumulation during aging. Cell Cycle 6, 2371–2376 (2007).

CA Whitlock, GF Tidmarsh, C Muller-Sieburg, IL Weissman, Bone marrow stromal cell lines with lymphopoietic activity express high levels of a pre-B neoplasia-associated molecule. Cell 48, 1009–1021 (1987).

F Ishikawa, et al., Development of functional human blood and immune systems in NOD/SCID/IL2 receptor gamma chain(null) mice. Blood 106, 1565–1573 (2005).

D Sahoo, et al., MiDReG: A method of mining developmentally regulated genes using Boolean implications. Proc Natl Acad Sci USA 107, 5732–5737 (2010).

D Sahoo, DL Dill, AJ Gentles, R Tibshirani, SK Plevritis, Boolean implication networks derived from large scale, whole genome microarray datasets. Genome Biol 9, R157, 1–R157.17. (2008).